Wexler William A.

SEC source: 0001493152-26-041132 · ownership.xml · derivative · entry 1

Wexler William A. · CIK 0001927975 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,943

Underlying: Common Stock · 5,943 shares

Expires 2036-08-31

F1 · derivative.exercise_date: Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.

SEC source: 0001493152-25-005722 · ownership.xml · derivative · entry 1

Wexler William A. · CIK 0001927975 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,533

Underlying: Common Stock · 124,533 shares

Expires 2035-02-07

F1 · derivative.exercise_date: Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.

SEC source: 0001062993-23-021111 · form4.xml · nonDerivative · entry 1

Wexler William A. · CIK 0001927975 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,811

F1 · kind: Reflects a pro rata distribution to the reporting person by OTR Acquisition Sponsor LLC of the issuer's common stock on November 15, 2023.

F1 · shares: Reflects a pro rata distribution to the reporting person by OTR Acquisition Sponsor LLC of the issuer's common stock on November 15, 2023.

SEC source: 0001062993-23-020812 · form4.xml · derivative · entry 1

Wexler William A. · CIK 0001927975 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,376

Underlying: Common Stock · 75,376 shares

Expires 2033-11-09

F2 · price: In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended September 30, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $10,000. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022.

F1 · derivative.exercise_date: Granted pursuant to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan. The options were fully vested on the date of grant.

SEC source: 0001062993-23-017439 · form4.xml · derivative · entry 1

Wexler William A. · CIK 0001927975 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,728

Underlying: Common Stock · 46,728 shares

Expires 2033-08-10

F1 · date: The option grant was approved by the registrant's board of directors on August 10, 2023, subject to stockholder approval of an amendment to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan (the "Plan") under which the option was granted. The registrant's stockholders approved the Plan amendment on August 31, 2023.

F3 · price: In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended June 30, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $10,000. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022.

F2 · derivative.exercise_date: The options became fully vested on the date the Plan amendment was approved by the registrant's stockholders.

SEC source: 0001062993-23-016521 · form4.xml · nonDerivative · entry 1

Wexler William A. · CIK 0001927975 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,698

F1 · kind: Reflects a pro rata distribution to the reporting person by OTR Acquisition Sponsor LLC of the issuer's common stock on August 11, 2023.

F1 · shares: Reflects a pro rata distribution to the reporting person by OTR Acquisition Sponsor LLC of the issuer's common stock on August 11, 2023.

SEC source: 0001062993-23-011258 · form4.xml · derivative · entry 1

Wexler William A. · CIK 0001927975 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,472

Underlying: Common Stock · 27,472 shares

Expires 2033-05-12

F2 · price: In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended March 31, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $10,000. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022.

F1 · derivative.exercise_date: Granted pursuant to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan. The options were fully vested on the date of grant.

SEC source: 0001062993-23-003853 · form4.xml · derivative · entry 1

Wexler William A. · CIK 0001927975 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,100

Underlying: Common Stock · 7,100 shares

Expires 2033-02-14

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments beginning on March 14, 2023 such that the option will be fully vested on February 14, 2024, subject to continuous service to the issuer through each vesting date.

SEC source: 0001062993-22-017761 · form4.xml · derivative · entry 1

Wexler William A. · CIK 0001927975 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,200

Underlying: Common Stock · 14,200 shares

Expires 2032-08-09

F1 · derivative.exercise_date: The stock option shall vest over three (3) years, with thirty-three and one-third percent (33 1/3%) of the shares of Common Stock underlying the option vesting on August 9, 2023 and the remainder vesting in equal monthly installments thereafter.

SEC source: 0001140361-22-028097 · form4.xml · derivative · entry 2

Wexler William A. · CIK 0001927975 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,800

Underlying: Common Stock, par value $0.005 per share · 165,800 shares

Expires 2032-08-01

F2 · derivative.exercise_date: The stock option vests and becomes exercisable over two years (subject to continued service), with 1/3 of the shares vesting on the grant date and the remaining shares vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0001140361-22-028097 · form4.xml · derivative · entry 1

Wexler William A. · CIK 0001927975 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,100

Underlying: Common Stock, par value $0.005 per share · 152,100 shares

Expires 2032-08-01

F1 · derivative.exercise_date: The stock option vests and becomes exercisable over one year (subject to continued service), with 25% of the shares vesting every three months from the grant date.